Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lucky Core Industries Limited, formerly known as ICI Pakistan Limited, is a leading diversified manufacturing and trading company based in Pakistan with a significant presence in the life sciences sector. The company operates through five business segments: Pharmaceuticals, Animal Health, Soda Ash, Polyester, and Chemicals & Agri Sciences. Its pharmaceutical division is a major growth engine, offering a broad portfolio of primary and specialty care products, including treatments for oncology, cardiology, and central nervous system disorders, through strategic partnerships with global leaders such as AstraZeneca and Pfizer. In 2024, the company expanded its manufacturing footprint by acquiring Pfizer's production facility in Karachi, reinforcing its commitment to providing high-quality healthcare solutions and essential medicines to the regional market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Core Industries.